Reducing contamination during blood tests: Magnolia Medical lands $46M to fuel growth
Magnolia’s Steripath product portfolio. (Magnolia Photo) Magnolia Medical Technologies, which markets devices to reduce blood sample contamination while puncturing the skin, has raised $46 million. The funding builds on a 65% increase in revenue last year, according to Magnolia chief commercial officer Robert Gerberich. The company’s devices are used to prevent the entry of bacteria…